Vascular endothelial growth factor gene polymorphisms in patients with rosacea: A case-control study - 27/07/19
Abstract |
Background |
Rosacea is a chronic disease that is characterized by facial skin inflammation and vascular abnormality. Vascular endothelial growth factor (VEGF) is a potent mediator of vascular permeability and inflammation that might play a role in the pathogenesis of rosacea.
Objective |
This study aimed to determine the association between VEGF gene polymorphisms and rosacea.
Methods |
A case-control study design was used to compare 100 patients with rosacea and 100 age- and gender-matched control subjects in terms of VEGF polymorphisms based on polymerase chain reaction and the serum level of VEGF and VEGF receptors based on enzyme-linked immunosorbent assay.
Results |
Heterozygous and homozygous +405C/G polymorphism of the VEGF gene was observed to increase the risk of rosacea 1.7-fold (95% confidence interval 1.2-4.2) and 2.3-fold (95% confidence interval 1.2-4.2), respectively. There was a significant positive correlation between the severity of rosacea and +405C/G polymorphism of the VEGF gene in patients with erythematotelangiectatic rosacea.
Limitations |
Serum VEGF and VEGF receptor levels were measured in the limited number of patients.
Conclusion |
The present findings indicate that +405C/G polymorphism of the VEGF gene increases the risk of rosacea.
Le texte complet de cet article est disponible en PDF.Key words : rosacea, vascular endothelial growth factor, VEGF gene polymorphism
Plan
Supported by an Hacettepe University Medical School research grant. |
|
Conflicts of interest: None disclosed. |
Vol 81 - N° 2
P. 348-354 - août 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?